JPMorgan raised the firm’s price target on Alignment Healthcare (ALHC) to $26 from $23 and keeps an Overweight rating on the shares.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ALHC:
- Alignment Healthcare price target raised to $28 from $22 at Baird
- Alignment Healthcare jumps after Baird analyst highlights on CNBC
- Alignment Healthcare price target raised to $28 from $21 at KeyBanc
- Alignment Healthcare appoints Mansour as Chief Digital Officer
- Alignment Healthcare price target raised to $25 from $18.50 at TD Cowen